Dave Feldman, an engineer known for his research on lean mass hyper-responders, Nick Norwitz, a human metabolism PhD from Oxford studying at Harvard, and Adrian Sotomata, a physician internist with an Oxford PhD, challenge conventional wisdom about LDL cholesterol. They discuss how high LDL levels don’t always indicate cardiovascular risk, emphasizing the importance of personalized health strategies and lifestyle choices. The conversation critiques traditional lipid management, explores the complexity of dietary influences, and highlights the need for nuanced approaches to health.
